Status:
COMPLETED
OPtimized Stenting Using Intravascular Ultrasound(IVUS) in Long lEsion: Rationale for Simplified criteriA
Lead Sponsor:
Centre Chirurgical Marie Lannelongue
Collaborating Sponsors:
Hôpital Cochin
Centre Hospitalier de La Rochelle
Conditions:
Coronary Heart Disease
Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Rationale IVUS has shown to be efficient for bare metal stent deployment, but has not been specifically studied for Drug Eluting Stents. The angiographically versus IVUS optimization (AVIO) study was ...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Patients who have had a coronary angioplasty with implantation of a TAXUS™ Element™ stent of 28, 32 and 38 mm in length and up to 3 stents per patient in the case of acute occlusive dissection deployed using IVUS
- Patients with indication of Taxus™ Element™ stent included in the List of Reimbursable Products and Supplies (LPPR):
- diabetes,
- small vessel (less than 3 mm in diameter),
- long lesion(s) (more than 15 mm long),
- chronic total occlusion \> 1 month,
- intra-stent restenosis with the exclusion drug eluting stent(s), restenosis of
- people with a lesion that is accessible to IVUS after stenting
- people who have provided consent for collection of medical data for this trial.
Exclusion
- Those who refuse to consent to the collection and/or processing of data necessary to complete the trial and/or the centralized follow-up
Key Trial Info
Start Date :
October 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2018
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01861860
Start Date
October 1 2012
End Date
July 1 2018
Last Update
January 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Chirurgical Marie Lannelongue
Le Plessis-Robinson, Île-de-France Region, France, 92350